These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6309944)

  • 1. The inhibitory effect of serum from diethyldithiocarbamate treated rats on bovine adrenal dopamine-beta-hydroxylase activity.
    Jarvis JA; Magos L; Jacobs R
    J Appl Toxicol; 1981 Feb; 1(1):26-9. PubMed ID: 6309944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dopamine-beta-hydroxylase inhibitors on thermoregulation in reserpine-treated rats.
    Ishii Y; Yoshikawa A; Homma M
    Neuropharmacology; 1976 Jun; 15(6):359-62. PubMed ID: 180451
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of dopamine beta-hydroxylase by 4-hydroxypyrazole: ethanol-pyrazole effects on serum dopamine beta-hydroxylase in vivo.
    Harralson JD; Wolfe BI; Brown FC
    J Pharmacol Exp Ther; 1978 Jul; 206(1):69-74. PubMed ID: 660559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of tyrosine and dopamine-beta-hydroxylases activities on disulfiram and diethyldithiocarbamate level in guinea pig brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):161-8. PubMed ID: 239396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory consolidation: further evidence for the four-phase model from the time-courses of diethyldithiocarbamate and ethacrynic acid amnesias.
    Frieder B; Allweis C
    Physiol Behav; 1982 Dec; 29(6):1071-5. PubMed ID: 6298844
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of dithiocarbamic acid as inhibitors of catecholamine biosynthesis (review of the literature)].
    Korablev MV; Kurbat NM
    Farmakol Toksikol; 1977; 40(2):230-8. PubMed ID: 15863
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum dopamine-beta-hydroxylase activity and dopamine-beta-hydroxylase and tyrosine hydroxylase activities in central and peripheral adrenergic neurons and adrenal glands.
    Nagatsu T; Kato T; Numata Y; Ikuta K; Sano M; Nagatsu I; Takeuchi T; Matsuzaki M; Umezawa H
    Experientia; 1977 May; 33(5):581-3. PubMed ID: 16769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine hydroxylase and dopamine beta-hydroxylase inhibiting properties of a new series of pyridazinyl hydrazones.
    Huszti Z; Szilágyi G; Kasztreiner E
    Biochem Pharmacol; 1983 Feb; 32(4):627-36. PubMed ID: 6131675
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenal origin of plasma catecholamines after decapitation: a study in normal and diabetic rats.
    Berkowitz BA; Head RJ
    Br J Pharmacol; 1978 Sep; 64(1):3-5. PubMed ID: 698480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-beta-hydroxylase activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
    Muñoz JA; García-Estañ J; Canteras M; Quesada T; Miras-Portugal MT
    Rev Esp Fisiol; 1986 Mar; 42(1):63-70. PubMed ID: 3520719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of dopamine-beta-hydroxylase in rat adrenals during exposure to carbon disulphide.
    Caroldi S; Jarvis JA; Magos L
    Arch Toxicol; 1984 Oct; 55(4):265-7. PubMed ID: 6517704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian changes in adrenal dopamine-beta-hydroxylase activity: dependency of change at darkness onset, and the effect of pinealectomy, on animal strain and age.
    Banerji TK; Kachi T; Quay WB
    Chronobiologia; 1979; 6(1):1-7. PubMed ID: 467170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathoadrenal activity and plasma glucose effects on plasma dopamine-beta-hydroxylase levels in rats.
    Muñoz JA; Garcia-Estañ J; Salom MG; Quesada T; Miras Portugal MT
    Clin Chim Acta; 1985 Nov; 152(3):243-52. PubMed ID: 4064332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon disulfide. II. A proposed mechanism for the action of carbon disulfide on dopamine beta-hydroxylase.
    McKenna MJ; DiStefano V
    J Pharmacol Exp Ther; 1977 Aug; 202(2):253-66. PubMed ID: 886465
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of brain tyrosine hydroxylase in rats exposed to carbon disulfide and sodium diethyldithiocarbamate.
    Heubusch P; DiStefano V
    Toxicol Appl Pharmacol; 1978 Oct; 46(1):143-9. PubMed ID: 31711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.